Related Experiment Video
Updated: Jul 5, 2026

QTL Mapping and CRISPR/Cas9 Editing to Identify a Drug Resistance Gene in Toxoplasma gondii
Published on: June 22, 2017
Forward genetics reveals microsporidian drug targets and recombination-based resistance
Qingyuan Huang1,2, Xianzhi Meng1,2, Winnie Zhao1
1Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
Abstract:
Microsporidia are diverse intracellular fungal parasites of humans and agriculturally important animals. Several inhibitors have been characterized, but their microsporidian targets and the mechanisms of resistance evolution remain unknown. Using C. elegans and its natural microsporidian parasite Nematocida parisii, we serially passaged infected animals under increasing inhibitor concentrations, generating independent N. parisii strains resistant to albendazole or dexrazoxane. The albendazole-resistant strains all contained either heterozygous or homozygous mutations in beta-tubulin, with several strains containing beta-tubulin variants that have been observed in other albendazole-resistant organisms. Strains containing homozygous variants are resistant to several albendazole analogs, whereas the heterozygous variant-containing strains are only resistant to albendazole. Several of the albendazole-resistant strains also contain mutations in alpha-tubulin. The dexrazoxane-resistant strains all contain heterozygous mutations in topoisomerase II, and several of these mutations occur in the binding site of this inhibitor. By mapping heterozygosity of the resistant strains across the N. parisii genome, we observed loss of heterozygosity spanning the beta-tubulin locus in the albendazole-resistant strains containing homozygous beta-tubulin variants. Our study demonstrates the utility of forward genetics for identifying microsporidian drug targets. We also find that drug resistance arises through de novo heterozygous mutations that can subsequently become homozygous, likely via mitotic recombination.
Insights
Researchers identified drug targets in microsporidia, which are fungal parasites. Drug resistance evolves through new mutations in genes like beta-tubulin and topoisomerase II, which can become homozygous.
Area of Science:
- Microbiology
- Parasitology
- Genetics
Background:
- Microsporidia are significant intracellular fungal parasites affecting humans and animals.
- Understanding microsporidian drug targets and resistance mechanisms is crucial but largely unknown.
Purpose of the Study:
- To identify drug targets in microsporidia using forward genetics.
- To elucidate the mechanisms of drug resistance evolution in microsporidian parasites.
Main Methods:
- Serial passage of Nematocida parisii (a microsporidian) in C. elegans under increasing drug concentrations (albendazole, dexrazoxane).
- Whole-genome sequencing and heterozygosity mapping to identify resistance-conferring mutations.
- Analysis of mutations in beta-tubulin, alpha-tubulin, and topoisomerase II.
Main Results:
- Albendazole resistance in N. parisii is associated with mutations in beta-tubulin (heterozygous or homozygous) and sometimes alpha-tubulin.
- Dexrazoxane resistance is linked to heterozygous mutations in topoisomerase II, including in the inhibitor's binding site.
- Loss of heterozygosity at the beta-tubulin locus was observed in strains with homozygous beta-tubulin variants.
Conclusions:
- Forward genetics is a powerful tool for discovering microsporidian drug targets.
- Drug resistance emerges from de novo heterozygous mutations that can subsequently become homozygous, likely through mitotic recombination.
More Related Videos
09:13Understanding the Development of Compensatory Pathways in a Mutant Malaria Parasite Harbouring Hypomorphic Allele of Plant-Like Kinases
Published on: November 22, 2024
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Fungal Phylum Microsporidia
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...